文献速递神经技术与安全MRUS

血清分离的细胞外囊泡对聚焦超声介导的血脑屏障开放的响应

Response of Serum-Isolated Extracellular Vesicles to Focused Ultrasound-Mediated Blood-Brain Barrier Opening.
PubMed 文献 · Ultrasound Med Biol · 2025-05-30

研究观察小鼠和阿尔茨海默病患者在聚焦超声介导血脑屏障开放后血清细胞外囊泡的浓度和内容物变化。小鼠治疗后1小时细胞外囊泡浓度增加164±85%,抑制细胞外囊泡可减少炎症反应和血脑屏障开放体积;患者治疗后1小时细胞外囊泡浓度也升高,且3天后与血脑屏障开放体积相关;分离细胞外囊泡可显著增强GFAP、β-淀粉样蛋白42和磷酸化tau 181等生物标志物的检测。

要点

  • 聚焦超声开放血脑屏障后1小时,小鼠和阿尔茨海默病患者血清细胞外囊泡浓度均升高。
  • 分离细胞外囊泡可增强聚焦超声诱导的阿尔茨海默病和中枢神经系统生物标志物检测。
  • 抑制细胞外囊泡可减少小鼠炎症反应和血脑屏障开放体积。

核心结论

  • 首次提供小鼠和阿尔茨海默病患者细胞外囊泡浓度及内容物响应聚焦超声开放血脑屏障的证据,提示细胞外囊泡在神经免疫治疗中的作用及改善生物标志物放大的效用。

研究设计与样本

  • 小鼠和阿尔茨海默病患者自身前后对照研究;小鼠于聚焦超声开放血脑屏障前和1小时后采血,患者于治疗前、1小时后和3天后采血;用Exoquick沉淀法分离血清细胞外囊泡,纳米颗粒跟踪分析定量浓度;小鼠细胞外囊泡行RNA测序和质谱蛋白分析;用GW4869药物抑制小鼠细胞外囊泡释放;患者细胞外囊泡生物标志物用Luminex多重检测。

诊断标准与关键数值

  • 小鼠治疗后1小时细胞外囊泡浓度增加164±85%(95%置信区间:78.998 - 249.202)。
  • 患者治疗后1小时细胞外囊泡浓度增加,且3天后与血脑屏障开放体积相关。
  • 分离细胞外囊泡较总血清显著增强(p<0.05)聚焦超声开放血脑屏障诱导的GFAP、β-淀粉样蛋白42和磷酸化tau 181等生物标志物放大,分离细胞外囊泡的生物标志物水平log倍数变化平均高1.2倍。

临床应用与阅片要点

  • 作者认为结果为聚焦超声开放血脑屏障后基于细胞外囊泡的液体活检用于无创监测神经退行性疾病患者疾病进展的临床应用铺平道路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To characterize the response of extracellular vesicles (EV) in the serum of mice and Alzheimer's disease (AD) patients following focused ultrasound (FUS)-mediated blood-brain barrier (BBB) opening (FUS-BBBO) as a means to improve liquid biopsy.

METHODS: Blood was collected from C57BL/6 mice before, and one hour after FUS-BBBO, and from AD patients before, one hour after, and three days after FUS-BBBO. EVs were isolated from serum using the Exoquick precipitation solution and their concentration was quantified using nanoparticle tracking analysis. The transcriptomic and proteomic content of EVs from mice was assessed using RNA sequencing and mass spectrometry protein analysis respectively. Additionally, the release of EVs in mice was inhibited using the GW4869 drug to assess the role of EVs in the restoration of the BBB. Finally, the biomarker content of EVs in AD patients was detected using a Luminex multiplex assay.

RESULTS: We observed a 164±85% (95% confidence interval: 78.998 - 249.202) increase in murine EV concentration one hour after treatment, as well as an increase in EV RNA associated with FUS-BBBO neuroimmunotherapy. Inhibition of EVs reduced the inflammatory response and BBBO volume in mice. Patient EV concentration also increased one hour after treatment and was dependent on the volume of BBB opening three days post-treatment. Furthermore, EV isolation was found to significantly enhance (p<0.05) the detection of FUS-BBBO-induced amplification of AD and CNS biomarkers such as GFAP, beta-amyloid 42 and phosphorylated tau 181, exhibiting on average a 1.2 times higher log-fold change in biomarker levels in isolated EVs compared to total serum.

CONCLUSION: Overall, we hereby present the first evidence of altered murine and AD patient EV concentration and content in response to FUS-BBBO, providing evidence of EVs' role within FUS-BBBO neuroimmunotherapy as well as their utility in improving FUS-BBBO biomarker amplification. Our results pave the way for clinical applications of EV-based liquid biopsy in patients with neurodegenerative diseases following FUS-BBBO, as a way of noninvasively monitoring disease progression.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Kline-Schoder AR, Tsitsos FN, Batts AJ, et al. Response of Serum-Isolated Extracellular Vesicles to Focused Ultrasound-Mediated Blood-Brain Barrier Opening. Ultrasound Med Biol. 2025. PMID: 40450507. doi:10.1016/j.ultrasmedbio.2025.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。